SCHEMBL1628605

SCHEMBL1628605

CCS(=O)(=O)Nc1nccnc1CNc1nc(Nc2cccc(C(N)=O)c2)ncc1C(F)(F)F

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1627664 0.91 PTK2 (0.72) PTK2
SCHEMBL14931404 0.90 PTK2 (0.72) PTK2
SCHEMBL14931354 0.88 PTK2 (0.73) PTK2
SCHEMBL14931296 0.86 PTK2 (0.74) PTK2
SCHEMBL14931303 0.85 PTK2 (0.65) PTK2
SCHEMBL14931447 0.85 PTK2 (0.74) PTK2
SCHEMBL14942343 0.85 PTK2 (0.74) PTK2
SCHEMBL1626811 0.85 PTK2 (1.00) PTK2
SCHEMBL29853754 0.85 PTK2 (1.00) PTK2
SCHEMBL14931405 0.84 PTK2 (0.75) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440822-B2 Sulfonyl amide derivatives for the treatment of abnormal cell growth PFIZER, INC. 2013-05-14 — — US disclosed
US-7928109-B2 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride PFIZER INC (US) 2011-04-19 — — US disclosed
Send feedback